Opella Delivers Strong Performance in First Year: Growth and Transformation in Self-Care

Opella, a standalone consumer health company completing its first year of operations, has achieved significant milestones in scientific research, sustainability and health literacy while continuing to expand on a global scale.

As Opella completed its first year operating as an independent consumer health company, it undertook important initiatives throughout 2025 that strengthened its leadership in self-care. The company, which maintains its position as the world's third-largest player in over-the-counter (OTC) products and vitamins, minerals and supplements (VMS) categories, has continued its investments in innovation, scientific research and sustainability at a steady pace.

Throughout the year, focused on generating scientific knowledge and developing health literacy, Opella secured acceptance for 37 scientific publications and launched 42 new research studies. The company also reached more than 158,000 healthcare professionals through educational programs, scientific meetings, symposiums and professional engagement activities.

Leading Steps in Sustainability
Achieving significant successes in sustainability, Opella became the first global consumer health company to receive B Corp certification. The company's net-zero emission targets were approved by the Science Based Targets initiative (SBTi). During the same period, Opella continued its investments to support annual production capacity exceeding 2 billion units.

"Making Self-Care More Accessible"
Feirouz Ellouze, General Manager of Opella Africa, Middle East and Turkey (AMET), commented on the company's first year:

"Our first year as an independent company has been a significant turning point in bringing our strategic priorities to life. We are advancing in line with our 'Your Health in Your Hands' approach by making self-care simpler, more intuitive and more accessible. While increasing access to science-based solutions in the AMET region, with Turkey at its centre, we take great pride in the impact created by our work strengthening health literacy."

Strong Local Impact in Turkey
Pelit Duman, General Manager of Opella Turkey, shared the following assessment regarding the company's operations in Turkey:

"While rapidly translating our global vision into strong local initiatives, we supported our successful business results with projects that create social benefit. Within the scope of our self-care focused work, we reached more than 10,000 children with Enterogermina®. With the launch of Pharmaton® Kiddi, we brought Pharmaton's trusted heritage to the field of children's health. The work we accomplished in our first year provides strong motivation for our goal to make self-care solutions even more widespread across Turkey."

Operating with a portfolio of more than 100 brands, Opella continues to reach millions of consumers worldwide with strong brands such as Enterogermina® and Pharmaton®. The company aims to continue expanding access to self-care solutions in line with innovation, digitalization and growth strategies in new markets in the coming period.